These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6151053)

  • 1. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
    Melbye M; Froebel KS; Madhok R; Biggar RJ; Sarin PS; Stenbjerg S; Lowe GD; Forbes CD; Goedert JJ; Gallo RC
    Lancet; 1984 Dec; 2(8417-8418):1444-6. PubMed ID: 6151053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters.
    Lindhardt BO; Gerstoft J; Ulrich K; Bentzen K; Scheibel E; Dalsgård Nielsen J; Dickmeiss E
    Scand J Haematol; 1985 Oct; 35(4):379-85. PubMed ID: 3001927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-III antibody and T-cell subset ratios in haemophiliacs and their spouses.
    McVerry BA; Machin SJ; Galloway MJ; McCarthy K; Evans P; Barnes RM; Turner GC; Cheingsong-Popov R; Tedder RS; Winter M
    Br J Haematol; 1986 Jun; 63(2):347-52. PubMed ID: 3013274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin.
    Felding P; Nilsson IM; Hansson BG; Biberfeld G
    Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551
    [No Abstract]   [Full Text] [Related]  

  • 5. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
    JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
    Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S
    Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate.
    van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR
    Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate.
    Goedert JJ; Sarngadharan MG; Eyster ME; Weiss SH; Bodner AJ; Gallo RC; Blattner WA
    Blood; 1985 Feb; 65(2):492-5. PubMed ID: 2981592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HTLV-III seropositivity in symptom-free Italian haemophiliacs. Correlation with consumption of commercial concentrate and abnormalities of T and B lymphocytes.
    Giudizi MG; Biagiotti R; Almerigogna F; Mazzetti M; Alessi A; Massai G; Longo G; Scano G; Morfini M; Romagnani S
    Scand J Haematol; 1986 Feb; 36(2):198-202. PubMed ID: 2422735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroconversion for HTLV-III since 1980 in British haemophiliacs.
    Machin SJ; McVerry BA; Cheingsong-Popov R; Tedder RS
    Lancet; 1985 Feb; 1(8424):336. PubMed ID: 2857382
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of antibodies to lymphadenopathy-AIDS virus in French haemophiliacs.
    Aymard JP; Janot C; Chermann JC; Montagnier L; Briquel ME; Legras B; Alexandre P; Streiff F
    Vox Sang; 1985; 49(2):161-3. PubMed ID: 2994302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus.
    Koerper MA; Kaminsky LS; Levy JA
    Lancet; 1985 Feb; 1(8423):275. PubMed ID: 2857339
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of heat-treated clotting-factor concentrates in patients with haemophilia and a high exposure to HTLV-III.
    McGrath KM; Thomas KB; Herrington RW; Turner PJ; Taylor L; Ekert H; Schiff P; Gust ID
    Med J Aust; 1985 Jul; 143(1):11-3. PubMed ID: 2989666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate.
    Rouzioux C; Chamaret S; Montagnier L; Carnelli V; Rolland G; Mannucci PM
    Lancet; 1985 Feb; 1(8423):271-2. PubMed ID: 2857333
    [No Abstract]   [Full Text] [Related]  

  • 15. One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates.
    Rodeghiero F; Castaman GC; Chisesi T; De Rossi A; Dalla Gassa O; Del Mistro A; Dini E; Castronovo S; Pornaro E; Chieco-Bianchi L
    Thromb Haemost; 1985 Oct; 54(3):665-8. PubMed ID: 3003954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
    J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the human T-cell lymphoma/leukemia virus type I in Dutch haemophiliacs.
    Goudsmit J; Miedema F; Breederveld C; Terpstra F; Roos M; Schellekens P; Melief C
    Vox Sang; 1986; 50(1):12-5. PubMed ID: 3006351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.
    Ludlam CA; Tucker J; Steel CM; Tedder RS; Cheingsong-Popov R; Weiss RA; McClelland DB; Philp I; Prescott RJ
    Lancet; 1985 Aug; 2(8449):233-6. PubMed ID: 2862416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacs.
    Kitchen LW; Barin F; Sullivan JL; McLane MF; Brettler DB; Levine PH; Essex M
    Nature; 1984 Nov 22-28; 312(5992):367-9. PubMed ID: 6095094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.